Technology

MSIG USA Appoints Tony Beirne and Dale James to Key Leadership Roles to Further Strengthen Risk Governance and Analytic Excellence

Published

12 months ago

May 7, 2025

NEW YORK, May 7, 2025 /PRNewswire/ — MSIG USA has appointed Tony Beirne as chief actuary and Dale James as chief risk officer, further strengthening the company’s leadership in analytics and enterprise risk governance. Both executives will report to Peter McKenna, chief executive officer.

“These appointments reflect MSIG USA’s continued focus on deepening our analytical and governance capabilities to support our long-term strategy,” McKenna said. “Beirne brings a modern, data-driven approach to actuarial leadership that will enhance our pricing and portfolio management. Dale’s experience in risk oversight, capital markets and ESG strengthens our ability to anticipate and manage risk in today’s complex insurance landscape. I’m looking forward to the impact both leaders will make to MSIG USA’s growth and resilience.”

Beirne joins MSIG USA with more than 20 years of actuarial experience across commercial insurance, consulting and insurtech. Most recently, he served as chief actuary at Cover Whale, where he led pricing model development, telematics scoring, and predictive analytics initiatives that supported rapid portfolio expansion. His previous roles include chief actuary and product officer at VoyageWorks, as well as positions with KPMG, PricewaterhouseCoopers, and Liberty Mutual.

As chief actuary, Beirne will lead MSIG USA’s actuarial function, overseeing reserving, pricing strategy, capital modeling and portfolio analytics. He will partner closely with underwriting and finance to ensure disciplined, insight-driven decision making across the enterprise.

James brings more than two decades of leadership experience in risk, capital management and corporate finance. He most recently served as vice president, corporate finance and chief risk officer at Alleghany Corp., where he led risk governance, including catastrophe exposure, capital adequacy, and reinsurance counterparty risk. Earlier in his career, James held roles at Goldman Sachs, JMMB and NCB Insurance.

In his role as chief risk officer, James will oversee MSIG USA’s enterprise risk management strategy, including risk governance, compliance oversight, and business continuity planning. He will work across functions to embed risk awareness into decision making and strengthen the company’s long-term operational resilience.

About MSIG USA

MSIG USA is the marketing term used to refer to MSIG Holdings (U.S.A.), Inc. (“MSIGH”), its insurance subsidiaries, and their managers. MSIGH’s insurers are Mitsui Sumitomo Insurance Company of America, Mitsui Sumitomo Insurance USA Inc., and MSIG Specialty Insurance USA Inc. The insurers are managed by Mitsui Sumitomo Marine Management (U.S.A.), Inc. and MSIG Insurance Services, Inc. MSIGH is a subsidiary of MS&AD Insurance Group Holdings, Inc., one of the world’s top P&C carriers with a 350-year heritage, A+, Class 15 ratings, and a global reach that spans 40+ countries and regions. Within Asia, MS&AD Insurance Group Holdings, Inc. is represented in all ASEAN markets as well as in Australia, New Zealand, Hong Kong, China, Korea, India and Taiwan. It is the top non-life regional insurance provider in ASEAN based on gross written premiums. MSIG USA brings the financial strength, underwriting expertise, exceptional claims management, global footprint, and innovation necessary to offer commercial insurance solutions that address unique risks businesses face in today’s market. Its nationwide network of over 500 professionals enables them to provide responsive and personalized service for their clients. The US-based insurance subsidiaries are admitted in all P&C lines in all 50 states, the District of Columbia, and Puerto Rico. Not all insurers do business in all jurisdictions. Actual coverage is subject to the language of the policies as issued. To learn more, visit www.msigusa.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/msig-usa-appoints-tony-beirne-and-dale-james-to-key-leadership-roles-to-further-strengthen-risk-governance-and-analytic-excellence-302448914.html

SOURCE MSIG USA

Technology

IGCS International Announces Strategic Equity Investment by Lacks Enterprises

Published

59 minutes ago

April 22, 2026

DALLAS, April 22, 2026 /PRNewswire/ — IGCS International, a CVE-certified SDVOSB and leading provider of mission support and MRO supplies to the U.S. Department of Defense and federal agencies, today announced that Lacks Enterprises has acquired an equity stake in the company.

The strategic investment combines IGCS’s expertise in government supply chain, logistics, and MRO solutions with Lacks Enterprises’ advanced manufacturing capabilities, including electroplating, injection molding, composites, and testing for aerospace and defense.

“IGCS has built a strong track record supporting the Department of Defense… Partnering with Lacks Enterprises allows us to integrate cutting-edge manufacturing innovation into our offerings,” said Russ Spears, President of IGCS International.

Media Contact: Russ Spears, 214-733-7278, russ@igcsintl.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/igcs-international-announces-strategic-equity-investment-by-lacks-enterprises-302750824.html

SOURCE IGCS International

Technology

Shoulder Innovations to Report First Quarter 2026 Financial Results on May 13, 2026

Published

59 minutes ago

April 22, 2026

GRAND RAPIDS, Mich., April 22, 2026 /PRNewswire/ — Shoulder Innovations, Inc. (“Shoulder Innovations”) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the first quarter of 2026 after market close on Wednesday, May 13, 2026.

Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on May 13, 2026. Those interested in listening to the conference call may do so by dialing (877) 407-8216 for domestic callers or (412) 902-1015 for international callers and providing access code 13759613. A live and archived webcast of the event will be available in the “Investor Relations” section of the Shoulder Innovations website at https://ir.shoulderinnovations.com/.

About Shoulder Innovations
Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations’ ecosystem, which is designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Shoulder Innovations’ ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.

Contact
Brian Johnston or Sam Bentzinger
Gilmartin Group LLC
ir@shoulderinnovations.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/shoulder-innovations-to-report-first-quarter-2026-financial-results-on-may-13-2026-302750154.html

SOURCE Shoulder Innovations

Technology

Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026

Published

59 minutes ago

April 22, 2026

MADISON, Wis., April 22, 2026 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2026, ended March 31, 2026, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on May 6, 2026.

The conference call dial-in numbers are 1-833-316-0563 (USA) or 1-412-317-5747 (international). In addition, a dial-up replay of the conference call will be available approximately one hour after the call’s conclusion for one week. The replay number is 1-855-669-9658 (USA) or 1-412-317-0088 (international), conference ID: 4178502.

A live webcast of the call will also be available from the Investor Relations section of the company’s website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the fourth quarter of fiscal 2026.

About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, X, and YouTube.

Investor and Media Contact
Steve Monroe
VP, Financial Planning & Analysis, Accuray
Investor.relations@accuray.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-to-report-third-quarter-fiscal-2026-financial-results-on-may-6-2026-302750641.html

SOURCE Accuray Incorporated